Biomarker insights impact factor 2015 pdf

The journal aims to be a venue for rapid communications in the field. Articles from biomarker insights are provided here courtesy of sage. The impact factor if or journal impact factor jif of an academic journal is a scientometric index that reflects the yearly average. Urinary nephrotoxicity biomarkers as assessed by immunoassays. It supports the communication of the latest advances in the identification of biomarkers, their application towards the discovery of new knowledge and their clinical application. Prognostic significance of neutrophil to lymphocyte ratio in several malignancies. Immune checkpoint molecules function to prevent autoimmunity and tissue damage during pathogenic infection. In a process referred to as adaptive immune resistance. Hepatocyte growth factor receptor, matrix metalloproteinase11, tissue inhibitor of metalloproteinase1, and fibronectin are upregulated in papillary thyroid carcinoma. To measure success rates for investigational drugs, we analyzed individual drug program phase transitions from january 1, 2006 to december 31, 2015. Biomarker identification through hypothesisbased methods is essentially a byproduct of the everincreasing mechanistic understanding of disease processes. Articles from biomarker insights are provided here courtesy of sage publications. Biomarkers in pharmaceutical research clinical chemistry. May 31, 2007 information about the openaccess journal biomarker insights in doaj.

Volume 25 2020 volume 24 2019 volume 23 2018 volume 22 2017 volume 21 2016 volume 20 2015 volume 19 2014 volume 18 20 volume 17 2012 volume 16 2011 volume 15 2010 volume 14 2009 volume 2008 volume 12 2007 volume 11 2006 volume 10. For example, knowledge that diabetes mellitus produces a sustained elevation of blood glucose levels led to the identification of glycosylated hemoglobin as a biomarker for diagnosis of. Biomarkers can be classified based on different parameters, including their characteristics. Circulating cellfree mirnas as biomarker for triplenegative. These molecules are inhibitory receptors expressed on the surfaces of t cells and tumor cells, and mediate the functional interaction between these cells.

The impact factor if or journal impact factor jif of an academic journal is a scientometric index that reflects the yearly average number of. Impact factor is measured based on the frequency with which a journals articles are cited in scientific publications, is a putative marker of journal quality. The open biomarkers journal rg journal impact rankings 2018. The impact factor quartile of biomarker insights is q2. To eliminate pain and suffering through the application of biochemistry to create new diagnostic tests and innovate drugs.

The journal was established in 2006 and was originally published by libertas academica. It provides the most comprehensive coverage in the field, spanning significant technical developments in all major gel and nongel based proteomic platforms and their application in every area of life sciences. Coherent market insights analysis 2018 growing research and development funding from various government and private organizations is a factor driving growth of the cancer biomarkers market. Liquid biopsies have emerged as a useful addition to tissue biopsies in the field of molecular pathology. It provides the rapid communication of the latest advances in the identification of biomarkers, their application towards the discovery of new knowledge and its clinical application. Highthroughput screening for biomarker discovery a special issue journal published by hindawi biomarkers are indicators of disease occurrence and progression. Immunomodulatory effects of probiotic supplementation in schizophrenia patients. Toward predictive models for druginduced liver injury in. Updated list of high journal impact factor biomarkers journals. Current biomarker findings ceased publishing in may 2018.

Biomarkers are referred to measurable indicator of some biologic condition or severity of disease state. If you would like to receive news updates about cancer biomarkers. Wasenius vm, hemmer s, kettunen e, knuutila s, franssila k, joensuu h. Clinical biomarkers impact factor impact factor is an indicator of the number of citations within the scientific journals of clinical and medical category. Browse the list of issues and latest articles from biomarkers. They can be used to assess normal biological and pathogenic processes, or pharmacologic responses to a therapeutic intervention, and in some cases they may serve as potential drugs and. Back in 2010 an article in the new yorker called the truth wears off addressed the concern of which results to believe when socalled validated findings could not be proven or replicated and led to retraction of scientific publications. Biomarker insights rg journal impact rankings 2018 and 2019. A fresh hope for cardiac regeneration exosomes and microrna.

This subtype often has early and high recurrence rates resulting in poor survival, partially due. Elevated serum sortilin is related to carotid plaque concomitant with calcification. Citescore values are based on citation counts in a given year e. Loss in body weight is an independent prognostic factor for. Differentiation is a multidisciplinary journal dealing with topics relating to cell differentiation, development, cellular structure and function, and cancer. The disease markers may include, but are not limited to, genomic. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. Cancer biomarkers impact factor if 201920182017 bioxbio. Plumx metrics top social media articles below is a recent list of 20192020 articles that have had the most social media attention. A randomized, placebocontrolled trial jakub tomasik, robert h. Biomarker tests can use one biomarker, or several biomarkers where each is used separately and where each gives an individual score, or alternatively, several biomarkers where data from all of the markers are processed by an algorithm to give a single score. According to the journal citation reports, the journal has a 2015 impact factor of 2. Clinical biomarkers impact factoromics international. The journal has enlarged its scope to include the expanding area of biomarkers of disease and now intends to include evidencebased pharmacodynamic markers.

Biomarker insights directory of open access journals. Impact factor is an indicator of the number of citations within the scientific journals of clinical and medical category. The discovery of biomarkers in cancer immunotherapy. The plum print next to each article shows the relative activity in each of these categories of metrics. Loss in body weight is an independent prognostic factor. Clinical biomarkers impact factoromics internationaljournal. Differentiation of eukaryotes at the molecular level and the use of transgenic and targeted mutagenesis approaches to problems of differentiation are of particular interest to the journal.

The clinical and prognostic significance of body weight in chronic heart failure hf patients has for many years been the subject of controversial reports, on one side supporting a protective role of conditions broadly coinciding with obesity, 1, 2 and on the other suggesting weight loss as a synonym of cardiac cachexia to be targeted with preventivetherapeutic interventions. A selection of important and recent patents on biomarkers is also included in the journal. Cardiovascular disease and micrornas biomarker insights. External quality assessment schemes for biomarker testing in. Exposure biomarkers would be those used for validating dietary measurement, or as a surrogate of dietary intake.

Clinical and biomarker predictors of expanded heart failure. This can help researchers develop more individualized treatments, provide an early warning sign for certain health risks and accelerate patient access. A biomarker bm is a substance that is measured in a biological system as an indicator of exposure, effect, susceptibility, or clinical disease 2,3. More generally a biomarker is anything that can be used as an indicator of a particular disease state or some other physiological state of an organism. Immunomodulatory effects of probiotic supplementation in. Biomarkers in medicine welcomes unsolicited article proposals. Highthroughput screening for biomarker discovery hindawi. This journal is a member of the committee on publication. In science, the buzz around the reproducibility topic has been going on for some time now. Biomarker research encompasses every aspect of biomarker investigation from all biomedical disciplines. Email us today to discuss the suitability of your research and our options for authors, including our accelerated publication and open access services. Previous literature has shown lower laboratory performances when a new technique or method for variant analysis is introduced.

Apr 23, 2015 triplenegative breast cancer tnbc accounts for 1520% of all breast cancer in women globally. Current biomarker findings dove press open access publisher. This study aimed to measure clinical development success rates to strengthen benchmarking metrics for drug development. A biomarker is a measure or physical sign that can be used to determine how the body is functioning. The coverage includes novel biomarkers in basic, medical, environmental, and pharmaceutical research. The journal recognizes that the study of biomarkers.

Design and analysis of biomarker studies for risk prediction. Proteomics is the premier international source for information on all aspects of applications and technologies in proteomics. All articles that have been published in current biomarker findings will continue to be available on the dove press site, and will be securely archived with clockss. The two years line is equivalent to journal impact factor thomson reuters metric. Journal of molecular biomarkers diagnosis request pdf. Clinical and biomarker predictors of expanded heart failure outcomes in patients with type 2 diabetes mellitus after a recent acute coronary syndrome. In the age of personalized medicine, biomarkers short for biological markers are emerging as important tools in drug development. The aim of this study was to evaluate the differences in variant analysis between tissue and plasma samples after its introduction as a new sample type for. A comprehensive guide to toxicology in nonclinical drug development second edition, 2017.

Manuscripts describing novel biomarkers and their subsequent validation are. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure. Judicious biomarker use can improve pharmaceutical development efficiency by helping to select patients most appropriate for treatment using a given mechanism, optimize dose selection, and provide earlier confidence in accelerating or discontinuing compounds in. Compared with historical impact factor data, the impact factor 2018 of biomarker insights dropped by 6. Impact factor of journal biomarkers in medicine 2016 2015. Biomarkers journals high impact articles list cancer. The journal biomarkers brings together all aspects of the rapidly growing field of biomarker research, encompassing their various uses and applications in one essential source. Apr 28, 2015 highthroughput screening for biomarker discovery a special issue journal published by hindawi biomarkers are indicators of disease occurrence and progression. Moreover, cdkn2a was differentially methylated between pancreatic cancer and chronic pancreatitis, which is a recognized risk factor for pancreatic cancer. Improving tissue regeneration after myocardial infarction is an important goal in cardiovascular research, to reduce the risk of recurring infarction and heart failure. A biomarker is a characteristic that is objectively measured and evaluated as an indicator of a normal biological process, a pathological process or. Discovery of candidate gene expression signatures in peripheral blood for the screening of cervical cancer. Design and analysis of biomarker studies for risk prediction yingye zheng fred hutchinson cancer research center, seattle wa november 18, 2015 yingye zheng design and analysis of biomarker studies november 18, 2015 1 94. Abhinav sharma, md, phd, muthiah vaduganathan, md, mph, joao pedro ferreira, md, phd, yuyin liu, msc, george l.

379 1454 457 1558 606 1431 998 684 1283 1192 875 1063 1430 711 44 1431 1209 1233 1182 905 1104 21 294 678 334 791 737 462 959 1254 1378 1468 316 353 633 672 966 900